We are pleased to advise that deep linking capability, enabling users to directly download individual mobile toolkits, has now been released on the RDS mobile app. You will see that each toolkit has a small QR code icon in the header area beside the search icon – see screenshot below. Clicking on this icon will open up a window with a full-size QR code and the alternative of a short URL for sharing with users. Instructions are provided.
You may need to actively update to the latest release - RDS app version 4.7.1 - to see this improvement.
Updating to this latest version of the RDS app is also strongly recommended to get the full benefits of the new resilience arrangements – specifically, that if the RDS website should fail, you will still be able to download new mobile app toolkits. To check your current RDS version, click on the three dots bottom right of the RDS app screen. This takes you to a “More” page where you will see the version number. To install latest updates:
On iPhones – go to the Apple store, click on your profile icon top right, scroll down to see the apps waiting to be updated and update the RDS app.
On Android phones – these can vary, but try going to the Google Play store, click on your profile icon top right, click on “Manage apps and device”, select and update the RDS app.
Please get in touch with ann.wales3@nhs.scot with any questions.
Starting dose: 1mg daily.
Dose escalation: No more than 1mg per week.
Maximum dose: Maximum dose should not exceed 0.12mg/kg.
|
Age |
Weight (kg) |
Maximum dose |
|
6-12 |
≥25 |
4mg |
|
13-17 |
34 to 41.4 |
4mg |
|
13-17 |
41.5 to 49.5 |
5mg |
|
13-17 |
49.5 to 58.4 |
6mg |
|
13-17 |
≥58.5 |
7mg |
|
Adult* |
≥58.5 |
7mg |
*Unlicensed
Dose should be reduced by half if concurrent use with moderate or potent inhibitors of CYP3A4 and ciprofloxacin.
Very common: Headache, somnolence, abdominal pain, fatigue
Common: Decreased appetite, depression, anxiety, insomnia, nightmares, dizziness, sedation, heart rate decreased, blood pressure decrease, nausea, vomiting, diarrhoea, irritability, rash
Uncommon: Agitation, aggression, hallucinations, convulsion, loss of consciousness, dyspepsia, tachycardia, pruritus.
See SPC for full details
Must be tapered with decrements of no more than 1 mg every 3 to 7 days, and blood pressure and pulse should be monitored to minimise potential withdrawal effects, in particular increases in blood pressure and heart rate.
MyPsych App